2013Medical Journal of BabylonRequires access

Pigment Epithelium-Derived Factor in Proliferative Diabetic Retinopathy

Seenaa Badr, Abdulhussein Alwan Algenabi, Salwa Jaber

Open publisher page 0 citations

Abstract

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus. Pigment epithelium-derived factor (PEDF) is a strong inhibitor of angiogenesis. Our aim was to address the predictive value of anti-angiogenic marker(PEDF) for progression of DR. A total of 118 subjects (healthy, diabetic without retinopathy and diabetic retinopathy) were studied.Serum angiogenic inhibitor PEDF were determined and the relationship between the DR, levels of PEDF, age, HbA1c, and duration of diabetes were evaluated. The mean of PEDF in sera of patients with proliferative diabetic retinopathy (6.74±2.20 Pg/ml) was significantly higher (p=0.01) than that of healthy control (4.25 ± 0.81 Pg/ml);So The levels of PEDF increases with progress of diabetic retinopathy and thus, increased levels of PEDF in the blood indicate microvascular damages in diabetic patients and may be predictor of the progression of DR.

About this research paper

What this paper is about

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus. Pigment epithelium-derived factor (PEDF) is a strong inhibitor of angiogenesis. Our aim was to address the predictive value of anti-angiogenic marker(PEDF) for progression of DR. A total of 118 subjects (healthy, diabetic without retinopathy and diabetic retinopathy) were studied.Serum angiogenic inhibitor PEDF were determined and the relationship between the DR, levels of PEDF, age, HbA1c, and duration of diabetes were evaluated. The mean of PEDF in sera of patients with proliferative diabetic retinopathy (6.74±2.20 Pg/ml) was significantly higher (p=0.01) than that of healthy control (4.25 ± 0.81 Pg/ml);So The levels of PEDF increases with progress of diabetic retinopathy and thus, increased levels of PEDF in the blood indicate microvascular damages in diabetic patients and may be predictor of the progression of DR.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus. Pigment epithelium-derived factor (PEDF) is a strong inhibitor of angiogenesis. Our aim was to address the predictive value of anti-angiogenic marker(PEDF) for progression of DR. A total of 118 subjects (healthy, diabetic without retinopathy and diabetic retinopathy) were studied.Serum angiogenic inhibitor PEDF were determined and the relationship between the DR, levels of PEDF, age, HbA1c, and duration of diabetes were evaluated. The mean of PEDF in sera of patients with proliferative diabetic retinopathy (6.74±2.20 Pg/ml) was significantly higher (p=0.01) than that of healthy control (4.25 ± 0.81 Pg/ml);So The levels of PEDF increases with progress of diabetic retinopathy and thus, increased levels of PEDF in the blood indicate microvascular damages in diabetic patients and may be predictor of the progression of DR.

Key concepts: PEDF, Medicine, Diabetic retinopathy, Retinopathy, Diabetes mellitus, Internal medicine, Angiogenesis, Complication

Related papers

Back to paper searchBrowse research topicsOriginal source
Pigment Epithelium-Derived Factor in Proliferative Diabetic Retinopathy — Research Paper | ScholarLens